These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 18665772

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. "IDEAL" vaccines for resource poor settings.
    Levine MM.
    Vaccine; 2011 Dec 30; 29 Suppl 4():D116-25. PubMed ID: 22486974
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera.
    Xu G, Wang S, Zhuang L, Hackett A, Gu L, Zhang L, Zhang C, Wang H, Huang Z, Lu S.
    Vaccine; 2009 Jun 12; 27(29):3821-30. PubMed ID: 19443090
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?
    Belyakov IM, Ahlers JD.
    J Immunol; 2009 Dec 01; 183(11):6883-92. PubMed ID: 19923474
    [Abstract] [Full Text] [Related]

  • 30. Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery.
    Devriendt B, De Geest BG, Goddeeris BM, Cox E.
    J Control Release; 2012 Jun 28; 160(3):431-9. PubMed ID: 22353618
    [Abstract] [Full Text] [Related]

  • 31. Japanese encephalitis globally and in India.
    Jacobson J, Sivalenka S.
    Indian J Public Health; 2004 Jun 28; 48(2):49-56. PubMed ID: 15709584
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Japanese encephalitis revisited.
    Diagana M, Preux PM, Dumas M.
    J Neurol Sci; 2007 Nov 15; 262(1-2):165-70. PubMed ID: 17643451
    [Abstract] [Full Text] [Related]

  • 34. Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects.
    Radosević K, Rodriguez A, Lemckert A, Goudsmit J.
    Expert Rev Vaccines; 2009 May 15; 8(5):577-92. PubMed ID: 19397415
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Intradermal vaccine delivery: will new delivery systems transform vaccine administration?
    Lambert PH, Laurent PE.
    Vaccine; 2008 Jun 19; 26(26):3197-208. PubMed ID: 18486285
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Recent progress in vaccines for amebiasis.
    Snow MJ, Stanley SL.
    Arch Med Res; 2006 Feb 19; 37(2):280-7. PubMed ID: 16380333
    [Abstract] [Full Text] [Related]

  • 40. Mucosal vaccines: novel advances in technology and delivery.
    Yuki Y, Kiyono H.
    Expert Rev Vaccines; 2009 Aug 19; 8(8):1083-97. PubMed ID: 19627189
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.